Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease

Volume: 7, Issue: 1, Pages: e000392 - e000392
Published: Feb 1, 2020
Abstract
Introduction Quercetin is a plant flavonoid and has potent antioxidant and anti-inflammatory properties. In a preclinical model of chronic obstructive pulmonary disease (COPD), quercetin reduced markers of both oxidative stress and lung inflammation and also reduced rhinovirus-induced progression of lung disease. Although quercetin appears to be an attractive natural alternative to manage COPD, the safety of quercetin supplementation in this...
Paper Details
Title
Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease
Published Date
Feb 1, 2020
Volume
7
Issue
1
Pages
e000392 - e000392
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.